tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Nigel Dally, 64 are a SELL (12.1%), 298 are a HOLD (56.33%), 167 are a BUY (31.57%).
Analyst Nigel Dally, currently employed at MORGAN STANLEY, carries an average stock price target met ratio of 79.19% that have a potential upside of 39.48% achieved within 350 days.
Nigel Dally’s has documented 1,023 price targets and ratings displayed on 24 stocks. The coverage is on Financial Services, Healthcare, Communication Services, Basic Materials sectors.
Most recent stock forecast was given on RGA, Reinsurance Group of America.
Analyst best performing recommendations are on ARQT (ARCUTIS BIOTHERAPEUTICS).
The best stock recommendation documented was for ARQT (ARCUTIS BIOTHERAPEUTICS) at 11/13/2023. The price target of $10 was fulfilled within 106 days with a profit of $7.89 (373.93%) receiving and performance score of 35.28.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 12-Aug-2024
$122
$8.28 (7.28%)
$120
1 months 10 days ago
(19-Aug-2026)
3/6 (50%)
$5.49 (4.71%)
66
Hold Since 21-Jul-2026
$116
$2.28 (2.00%)
$117
1 months 18 days ago
(11-Aug-2026)
2/2 (100%)
$-4.46 (-3.70%)
25
Hold Since 27-Aug-2015
$125
$11.28 (9.92%)
$120
1 months 18 days ago
(11-Aug-2026)
11/12 (91.67%)
$4.54 (3.77%)
163
Buy Since 03-Apr-2020
$138
$24.28 (21.35%)
$130
1 months 19 days ago
(10-Aug-2026)
16/18 (88.89%)
$16.67 (13.74%)
321
Sell Since 03-Dec-2021
$99
$-14.72 (-12.94%)
$98
1 months 22 days ago
(07-Aug-2026)
7/12 (58.33%)
$-24.99 (-20.15%)
153
Which stock is Nigel Dally most bullish on?
Which stock is Nigel Dally most reserved on?
What Year was the first public recommendation made by Nigel Dally?
